Roger Aston
Président chez RESP HEAL
Fortune : 2 M $ au 30/04/2024
Profil
Dr. Roger Aston is a Non-Executive Chairman at ResApp Health Ltd., a Chairman at Cynata, Inc., a Chief Executive Officer at pSiMedica Ltd., a Chief Executive Officer at pSiOncology Pte Ltd.
and an Executive Chairman at Biolife Science Ltd.
He is on the Board of Directors at Pitney Pharmaceuticals Pty Ltd.
Dr. Aston was previously employed as a Non-Executive Director by Calzada Ltd., a Non-Executive Chairman by PharmAust Ltd., a Non-Executive Director by OncoSil Medical Ltd., a Non-Executive Chairman by Regeneus Ltd., a Non-Executive Director by Idt Australia Ltd., an Independent Non-Executive Director by Immuron Ltd., a Non-Executive Director by Genepharm Australasia Ltd., a Non-Executive Chairman by Ascent Pharmahealth Pty Ltd., a Chairman & Chief Executive Officer by Halcygen Pharmaceuticals Ltd., a Chief Executive Officer & Director by Mayne Pharma Group Ltd., a Non-Executive Director by Clinuvel Pharmaceuticals Ltd., an Executive Chairman by Acuvax Ltd., a Chief Executive Officer by Arana Therapeutics Ltd., a Chief Executive Officer by Biokine Technology Ltd., a Chairman by Cambridge Discovery Ltd., a Chief Executive Officer by Hospira Australia Pty Ltd., and a Chairman by Imugene Ltd.
He also served on the board at pSivida Ltd., Bio Focus Co. Ltd., Cambridge Drug Discovery Holdings Ltd.
and MedImmune Ltd.
He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Manchester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMAUST LIMITED
3,81% | 09/05/2024 | 15 044 815 ( 3,81% ) | 2 M $ | 30/04/2024 |
IMMURON LIMITED
0,67% | 20/09/2023 | 1 520 376 ( 0,67% ) | 98 733 $ | 30/04/2024 |
Postes actifs de Roger Aston
| Sociétés | Poste | Début |
|---|---|---|
| RESP HEAL | Président | 02/07/2015 |
| pSiOncology Pte Ltd. | Directeur Général | - |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Directeur Général | - |
Cynata, Inc.
 Cynata, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Cynata Therapeutics Ltd., Cynata, Inc. is a clinical-stage biotechnology company based in Blackburn, Australia. The company listed on the Australian Securities Exchange in November 2013, following a reverse takeover of Eco Quest Ltd. Cynata's Cymerus™ technology addresses the complexities and challenges of manufacturing stem cells at commercial scale, specifically targeting ARDS, an inflammatory process leading to respiratory failure. The technology is based on mesenchymoangioblasts (MCAs), which are versatile stem cells. The company was founded by Ian Dixon. Cynata was acquired by Cynata Therapeutics Ltd. on December 01, 2013. | Président | - |
Biolife Science Ltd.
 Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million. | Président | - |
Pitney Pharmaceuticals Pty Ltd.
 Pitney Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of PharmAust Ltd., Pitney Pharmaceuticals Pty Ltd. provides medical and pharmaceutical services. The company is based in Kogarah, Australia. The CEO of the Australian company is Richard Mollard. Pitney Pharmaceuticals was acquired by PharmAust Ltd. on August 13, 2013 for $8.18 million. | Fondateur | - |
Anciens postes connus de Roger Aston
| Sociétés | Poste | Fin |
|---|---|---|
| IMMURON LIMITED | Président | 01/07/2023 |
| PHARMAUST LIMITED | Directeur Général | 01/09/2023 |
| ONCOSIL MEDICAL LIMITED | Président | 08/05/2017 |
| ░░░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Roger Aston
| The University of Manchester | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| IDT AUSTRALIA LIMITED | Health Technology |
| IMUGENE LIMITED | Health Technology |
| CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
| POLYNOVO LIMITED | Health Technology |
| IMMURON LIMITED | Health Technology |
| PHARMAUST LIMITED | Health Technology |
| ONCOSIL MEDICAL LIMITED | Health Technology |
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| Entreprise privées | 19 |
|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Genepharm Australasia Ltd.
 Genepharm Australasia Ltd. Pharmaceuticals: MajorHealth Technology Genepharm Australasia Ltd. is a specialist generic pharmaceutical company committed to the development, marketing and distribution of a premium range of generic pharmaceuticals. Genepharm was incorporated in 2003 to specifically enter into an exclusive distribution arrangement with the Genepharm Group, in order to bring to the Australian and New Zealand pharmaceutical markets the extensive range of products currently manufactured and distributed by Genepharm SA in Europe, and the future product pipeline of major generic prescription pharmaceuticals under development | Health Technology |
ResApp Health Ltd.
 ResApp Health Ltd. Packaged SoftwareTechnology Services ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The technology is based on a machine learning algorithm that uses sound alone without the need for additional hardware to diagnose and measure the severity of a respiratory condition. ResApp’s core technology uses sound to diagnose respiratory diseases including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease and asthma. The company was founded on September 13, 2000 by John Majewski and is headquartered in Brisbane, Australia. | Technology Services |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Health Technology |
Arana Therapeutics Ltd.
 Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia. | Health Technology |
Acuvax Ltd.
 Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Health Technology |
Cambridge Drug Discovery Holdings Ltd.
 Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne. | Commercial Services |
pSiMedica Ltd.
pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Commercial Services |
Ascent Pharmahealth Pty Ltd.
 Ascent Pharmahealth Pty Ltd. Pharmaceuticals: MajorHealth Technology Ascent Pharmahealth Pty Ltd. manufactures and supplies generic pharmaceuticals. It offers skincare, private prescription medicine, and dermorganics. The company was founded by Dennis Bastas in December 2003 and is headquartered in Australia. | Health Technology |
| pSivida Ltd. | Health Technology |
Hospira Australia Pty Ltd.
 Hospira Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Hospira Australia Pty Ltd. is an Australian company that manufactures and markets medication delivery systems. The company is based in Melbourne, Australia. | Health Technology |
| Cambridge Discovery Ltd. | |
| pSiOncology Pte Ltd. | |
| Biokine Technology Ltd. | |
Cynata, Inc.
Cynata, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Cynata Therapeutics Ltd., Cynata, Inc. is a clinical-stage biotechnology company based in Blackburn, Australia. The company listed on the Australian Securities Exchange in November 2013, following a reverse takeover of Eco Quest Ltd. Cynata's Cymerus™ technology addresses the complexities and challenges of manufacturing stem cells at commercial scale, specifically targeting ARDS, an inflammatory process leading to respiratory failure. The technology is based on mesenchymoangioblasts (MCAs), which are versatile stem cells. The company was founded by Ian Dixon. Cynata was acquired by Cynata Therapeutics Ltd. on December 01, 2013. | Commercial Services |
Biolife Science Ltd.
Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million. | Health Technology |
Pitney Pharmaceuticals Pty Ltd.
Pitney Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of PharmAust Ltd., Pitney Pharmaceuticals Pty Ltd. provides medical and pharmaceutical services. The company is based in Kogarah, Australia. The CEO of the Australian company is Richard Mollard. Pitney Pharmaceuticals was acquired by PharmAust Ltd. on August 13, 2013 for $8.18 million. | Health Technology |
Regeneus Ltd.
 Regeneus Ltd. Pharmaceuticals: MajorHealth Technology Regeneus Ltd. is regenerative medicine company, which develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Paddington, Australia. | Health Technology |
Bio Focus Co. Ltd.
 Bio Focus Co. Ltd. Medical SpecialtiesHealth Technology Part of NanoenTek, Inc., Bio Focus Co. Ltd. is a South Korean company that manufactures and distributes medical instruments. The company is based in Euwang, South Korea. The CEO of the company is Jung-Goo Seo. Bio Focus Co. was acquired by NanoenTek, Inc. on September 11, 2015 for $4.89 million. | Health Technology |
